Advanced search
Publication Cover
Current Medical Research and Opinion Volume 33, 2017 - Issue 7
Submit an article Journal homepage
756
Views
47
CrossRef citations to date
0
Altmetric
Cardiovascular

Different approaches to the assessment of adherence and persistence with cardiovascular-disease preventive medications

Sara MaloDepartment of Preventive Medicine and Public Health, University of Zaragoza, Zaragoza, Spain; ;Fundación Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-7194-8275
ORCID Icon,
Isabel Aguilar-PalacioDepartment of Preventive Medicine and Public Health, University of Zaragoza, Zaragoza, Spain; ;Fundación Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain; ORCID Iconhttp://orcid.org/0000-0001-7293-701X
ORCID Icon,
Cristina FejaDepartment of Preventive Medicine and Public Health, University of Zaragoza, Zaragoza, Spain; ;Fundación Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain; ORCID Iconhttp://orcid.org/0000-0002-2712-6709
ORCID Icon,
María Jesús LallanaFundación Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain; ;Pharmacy Service in Primary Health Care, Aragones Health Service, Zaragoza, Spain;
,
María José RabanaqueDepartment of Preventive Medicine and Public Health, University of Zaragoza, Zaragoza, Spain; ;Fundación Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain; ORCID Iconhttp://orcid.org/0000-0002-6671-5661
ORCID Icon,
Javier ArmestoPharmacy Service, Aragones Health Service, Zaragoza, Spain;
&
Enrica MendittoCenter of Pharmacoeconomics (CIRFF), University of Naples Federico II, Naples, Italy
 show all
Pages 1329-1336 | Received 19 Dec 2016, Accepted 31 Mar 2017, Published online: 19 May 2017

References

  • Chowdhury R, Khan H, Heydon E, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J 2013;34:2940-8
  • Hasford J, Schroder-Bernhardi D, Rottenkolber M, et al. Persistence with antihypertensive treatments: results of a 3-year follow-up cohort study. Eur J Clin Pharmacol 2007;63:1055-61
  • Ferrajolo C, Arcoraci V, Sullo MG, et al. Pattern of statin use in southern Italian primary care: can prescription databases be used for monitoring long-term adherence to the treatment? PLoS One 2014;9:e102146
  • Citarella A, Linder M, Kieler H, et al. Influence of baseline low-density lipoprotein cholesterol values on statin therapy persistence. Eur J Clin Pharmacol 2016;72:349-57
  • Andrade SE, Kahler KH, Frech F, et al. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006;15:565-74; discussion 75-7
  • Hess LM, Raebel MA, Conner DA, et al. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 2006;40:1280-8
  • Martin BC, Wiley-Exley EK, Richards S, et al. Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication. Ann Pharmacother 2009;43:36-44
  • Caetano PA, Lam JM, Morgan SG. Toward a standard definition and measurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization. Clin Ther 2006;28:1411-24; discussion 0
  • Arnet I, Kooij MJ, Messerli M, et al. Proposal of standardization to assess adherence with medication records: methodology matters. Ann Pharmacother 2016;50:360-8
  • Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 2012;73:691-705
  • Karve S, Cleves MA, Helm M, et al. Prospective validation of eight different adherence measures for use with administrative claims data among patients with schizophrenia. Value Health 2009;12:989-95
  • Choudhry NK, Shrank WH, Levin RL, et al. Measuring concurrent adherence to multiple related medications. Am J Manag Care 2009;15:457-64
  • Sinnott SJ, Polinski JM, Byrne S, et al. Measuring drug exposure: concordance between defined daily dose and days’ supply depended on drug class. J Clin Epidemiol 2016;69:107-13
  • World Health Organization Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index Oslo, Norway: Norwegian Institute of Public Health, 2016. Available at: http://www.whocc.no/atc_ddd_index/ [Last accessed 5 May 2016]
  • Casasnovas JA, Alcaide V, Civeira F, et al. Aragon workers’ health study – design and cohort description. BMC Cardiovasc Disord 2012;12:45
  • Malo S, Poblador-Plou B, Prados-Torres A, et al. Poor congruence with guidelines in the use of antibiotics for acute bronchitis: a descriptive study based on electronic health records. Fam Pract 2016;33:471-5
  • Deambrosis P, Saramin C, Terrazzani G, et al. Evaluation of the prescription and utilization patterns of statins in an Italian local health unit during the period 1994–2003. Eur J Clin Pharmacol 2007;63:197-203
  • Doro P, Benko R, Kosik E, et al. Utilization of oral antihyperglycemic drugs over a 7-year period (1998–2004) in a Hungarian population and adherence to drug therapy. Eur J Clin Pharmacol 2005;61:893-7
  • Farmer AJ, Rodgers LR, Lonergan M, et al. Adherence to oral glucose-lowering therapies and associations with 1-year HbA1c: a retrospective cohort analysis in a large primary care database. Diabetes Care 2016;39:258-63
  • Kirkman MS, Rowan-Martin MT, Levin R, et al. Determinants of adherence to diabetes medications: findings from a large pharmacy claims database. Diabetes Care 2015;38:604-9
  • Hoer A, Gothe H, Khan ZM, et al. Persistence and adherence with antihypertensive drug therapy in a German sickness fund population. J Hum Hypertens 2007;21:744-6
  • Qvarnstrom M, Kahan T, Kieler H, et al. Persistence to antihypertensive drug treatment in Swedish primary healthcare. Eur J Clin Pharmacol 2013;69:1955-64
  • Mazzaglia G, Ambrosioni E, Alacqua M, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009;120:1598-605
  • Perreault S, Dragomir A, Blais L, et al. Impact of adherence to statins on chronic heart failure in primary prevention. Br J Clin Pharmacol 2008;66:706-16
  • Halpern MT, Khan ZM, Schmier JK, et al. Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension 2006;47:1039-48
  • Yeaw J, Benner JS, Walt JG, et al. Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm 2009;15:728-40

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.